Drug Profile
Immune globulin 5% - Octapharma
Alternative Names: octagam; Octagam; Octagam 5%; Octagam® Immune Globulin Intravenous (Human) 5% Liquid PreparationLatest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator Octapharma
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Serum globulins; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Immunodeficiency disorders
- Discontinued Multiple sclerosis
Most Recent Events
- 05 Apr 2021 Discontinued - Phase-III for Multiple sclerosis in Austria (IV) (EudraCT2012-005086-12)
- 05 Apr 2021 Discontinued - Phase-III for Multiple sclerosis in Bulgaria (IV) (EudraCT2012-005086-12)
- 05 Apr 2021 Discontinued - Phase-III for Multiple sclerosis in Germany (IV) (EudraCT2012-005086-12)